Catalyst Wire Dossier Catalyst Wire Dossier

Zeposia (ozanimod)

ozanimod · Bristol Myers Squibb
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Zeposia (ozanimod), covering 2025-06-26 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod [Phase 4]

See pricing